Healthcare, Pharmaceuticals & Biotech

2016 Global Healthcare M&A deals broke records and in 2017 healthcare finance activity will stay high.

The healthcare market is continuously evolving. This is mainly due to an ageing population, efficiency improvements, disease management, emerging regions, new diagnostics and therapies. The most important growth areas are within Biotech, Software and Service Provision.

Over 10,000 transactions are closed annually in this area. 60% in the US, and 25% in Europe.

Pharmaceuticals and Biotech represent over 40% of the deals, with service and product suppliers coming in second and third consecutively.

Almost 70% of the deals are smaller than $100m.


Head of the Healthcare industry team:
Marc DeClerck, CDI Global Antwerp

Healthcare team members:
Philippe Tischhauser
Thierry Gibert
Olivier Chantre
Frank Govaert
Helene Morne
Aline Pajolec
Amanda Norre
Adrian Gilson
Bill Surman


View all transactions